Kymera Therapeutics, Inc. revenue breakdown overview

Kymera Therapeutics, Inc. revenue for the last year amounted to 78.59 M USD, the most of which — 78.59 M USD — came from its highest performing source at the moment, Small Molecule Therapeutics, the year earlier bringing 46.83 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Kymera Therapeutics, Inc. 78.59 M USD, and the year before that — 46.83 M USD.